Cardiac sarcoidosis, a rare disease?

1Sharma OP, Defining sarcoidosis. In: Mitchell D, Wells A, Spiro S, Moller D, (eds.) Sarcoidosis. Boca Raton: CRC Press; 2012.SharmaOPDefining sarcoidosisIn:MitchellDWellsASpiroSMollerD(eds.)SarcoidosisBoca RatonCRC Press201210.1201/b13322-4Search in Google Scholar

2Thillai M, Wickremasinghe M, Lalvani A, Moller D, Mitchell D. Etiology. In: Mitchell D, Wells A, Spiro S, Moller D. (eds.) Sarcoidosis. Boca Raton: CRC Press; 2012. p.27–40.ThillaiMWickremasingheMLalvaniAMollerDMitchellDEtiologyIn:MitchellDWellsASpiroSMollerD(eds.)SarcoidosisBoca RatonCRC Press20122740Search in Google Scholar

3Lyne JC, Savage HO, Oldershaw PJ. The heart. In: Mitchell D, Wells A, Spiro S, Moller D. (eds.) Sarcoidosis. Boca Raton: CRC Press; 2012.LyneJCSavageHOOldershawPJThe heartIn:MitchellDWellsASpiroSMollerD(eds.)SarcoidosisBoca RatonCRC Press2012Search in Google Scholar

4Ribeiro Neto ML, Jellis CL, Joyce E, Callahan TD, Hachamovitch R, Culver DA, Update in cardiac sarcoidosis. Annals ATS 16, 11, 2019, doi:10.1513/AnnalsATS.201902-119CME.Ribeiro NetoMLJellisCLJoyceECallahanTDHachamovitchRCulverDAUpdate in cardiac sarcoidosisAnnals ATS1611201910.1513/AnnalsATS.201902-119CME31322914Open DOISearch in Google Scholar

5Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. American Heart Journal. 2005;150: 459–463.ArdehaliHHowardDLHaririAQasimAHareJMBaughmanKLA positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathyAmerican Heart Journal200515045946310.1016/j.ahj.2004.10.00616169324Search in Google Scholar

6Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, et al. The WASOG sarcoidosis organ assessment instrument: un update of a previous clinical tool. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2014;31; 19–27.JudsonMACostabelUDrentMWellsAMaierLKothLThe WASOG sarcoidosis organ assessment instrument: un update of a previous clinical toolSarcoidosis Vasculitis and Diffuse Lung Diseases2014311927Search in Google Scholar

7Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131: 624–632.KandolinRLehtonenJAiraksinenJVihinenTMiettinenHYlitaloKCardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide studyCirculation201513162463210.1161/CIRCULATIONAHA.114.01152225527698Search in Google Scholar

8Schulz-Menger J, Wassmuth R, Abdel-Aty H, Siegel I, Franke A, Dietz R, et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2006;92: 399–400.Schulz-MengerJWassmuthRAbdel-AtyHSiegelIFrankeADietzRPatterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonanceHeart20069239940010.1136/hrt.2004.058016186083716501203Search in Google Scholar

9Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. Journal of the American College of Cardiology. 2014;63: 329–336.BlanksteinROsborneMNayaMWallerAKimCKMurthyVLCardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosisJournal of the American College of Cardiology20146332933610.1016/j.jacc.2013.09.022395573024140661Search in Google Scholar

10Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko V, Saranovic D, et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. Journal of Nuclear Medicine. 2012;53: 1543–1549.Sobic-SaranovicDGrozdicIVidenovic-IvanovJVucinic-MihailovicVArtikoVSaranovicDThe utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosisJournal of Nuclear Medicine2012531543154910.2967/jnumed.112.10438022879080Search in Google Scholar

11Baughman RP, Judson MA, Wells A. The indication for the treatment of sarcoidosis: wells law. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2017;34: 280–282. doi:10.36141/svdld.v34i4.6954.BaughmanRPJudsonMAWellsAThe indication for the treatment of sarcoidosis: wells lawSarcoidosis Vasculitis and Diffuse Lung Diseases20173428028210.36141/svdld.v34i4.6954Open DOISearch in Google Scholar

12Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004;83: 315–334.Chapelon-AbricCde ZuttereDDuhautPVeyssierPWechslerBHuongDLCardiac sarcoidosis: a retrospective study of 41 casesMedicine (Baltimore)20048331533410.1097/01.md.0000145367.17934.7515525844Search in Google Scholar

13Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Canadian Journal of Cardiology. 2013;29: 1034–1041.SadekMMYungDBirnieDHBeanlandsRSNeryPBCorticosteroid therapy for cardiac sarcoidosis: a systematic reviewCanadian Journal of Cardiology2013291034104110.1016/j.cjca.2013.02.00423623644Search in Google Scholar

14Nagai S, Yokomatsu T, Tanizawa K, Ikezoe K, Handa T, Ito Y, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Internal Medicine. 2014;53: 427–433.NagaiSYokomatsuTTanizawaKIkezoeKHandaTItoYTreatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesionsInternal Medicine20145342743310.2169/internalmedicine.53.079424583430Search in Google Scholar

15Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythms. 2014;11: 1305–1323.BirnieDHSauerWHBogunFCooperJMCulverDADuvernoyCSHRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosisHeart Rhythms2014111305132310.1016/j.hrthm.2014.03.04324819193Search in Google Scholar

16Kiko T, Yoshihisa A, Kanno Y, Yokokawa T, Abe S, Miyata-Tatsumi M, et al. A multiple biomarker approach in patients with cardiac sarcoidosis. International Heart Journal. 2018;59: 996–1001.KikoTYoshihisaAKannoYYokokawaTAbeSMiyata-TatsumiMA multiple biomarker approach in patients with cardiac sarcoidosisInternational Heart Journal201859996100110.1536/ihj.17-69530101857Search in Google Scholar

17Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP. Cardiac sarcoidosis: the impact of age and implanted devices on survival. Chest. 2017;151: 139–148.ZhouYLowerEELiHPCosteaAAttariMBaughmanRPCardiac sarcoidosis: the impact of age and implanted devices on survivalChest201715113914810.1016/j.chest.2016.08.145727614001Search in Google Scholar